Meet the OBR Editorial Board

Editor's Note: At OBR we have created an editorial board of renown thought leaders in different cancer disease areas. The role of our editorial board is to provide valuable insights through editorial commentary accompanying our daily news. We call it virtual access. By providing our insights into the daily news, you will have access into how these thought leading oncologists interpret the oncology news and events we carry in OBR daily. We hope that our editorial boards's insights will bring great value to the oncology community.

View all Editorial Board Member Commentary

Browse Editors by Section

member-photo

Debu Tripathy, MD

Professor and Chair, Department of Breast Medical Oncology The University of Texas MD Anderson Cancer Center

Comments

Scientists Identify Unique Genomic Features in Testicular Cancer

quotesThese findings are an example of the power of genomic sequencing and bioinformatic analysis - with a…quotes

member-photo

Howard S. Hochster, MD

Associate Cancer Center Director, Yale Cancer Center Professor of Medicine, Yale School of Medicine New Haven, CT 06520

Comments

Robert Comis, Piano Man, Clinical Trials Impresario, and ECOG-ACRIN Co-chair, Dies Unexpectedly at 71

quotesDr Bob Comis was a stolid and long-term leader of the old cooperative group system. He helped lead …quotes

member-photo

Richard Goldberg, MD

Director WVU Cancer Institute Director of Cancer Signature Program Laurence S. and Jean J. DeLynn Chair of Oncology

Comments

Study Examines 'Watch-And-Wait' Approach for People with Rectal Cancer

quotesThis is a very interesting study that opens the door to prospective investigation of a randomized tr…quotes

member-photo

Ted Okon

Executive Director Community Oncology Alliance

Comments

Sanofi Pegs U.S. Drug Price Rises to Below Healthcare Inflation

quotesAnother company making the right move to control drug prices, especially in cancer. In community onc…quotes

member-photo

William McGivney, PhD

National Health Policy Expert

Comments

Value-Based Oncology Care an Imperfect Proposition Still

quotesThe developers of Value Metric Frameworks continue to struggle to make them relevant and also to mak…quotes

member-photo

H. Jack West, MD

Medical Director, Thoracic Oncology Program, Swedish Cancer Institute, Seattle, WA; CEO, Global Resource for Advancing Cancer Education (GRACE)

Comments

Incyte Shares Jump After 'IDO' Cancer Immunotherapy Combo Data Revealed

quotesIn the feeding frenzy that is the business world's hype-driven interpretation of immunotherapy data,…quotes

member-photo

Winston Wong, PharmD

President, W-Squared Group

Comments

Congressman, Pharmacist, and Lawyer Debate PBMs, Drug Prices at Annual COA Meeting

quotesDefinitely a very volatile topic. PBMs control a good part of the prescription claims process, but …quotes

member-photo

Michael G. King Jr.

Managing Director and Senior Biotechnology Analyst

Comments

U.S. Food and Drug Administration Approves POMALYST® (pomalidomide) for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma

quotesI am excited to be joining the editorial board on OBR; I have been a fan of the publication since it…quotes

member-photo

Jennifer Levin Carter, MD, MPH

Chief Medical Officer and Founder, N-of-One

No comments to show!

member-photo

Robert A. Figlin, MD., FACP

Professor and Director, Division of Hematology Oncology Department of Medicine,Cedars-Sinai Medical Center Associate Director for Academic Program Development Samuel Oschin Comprehensive Cancer Institute Professor of Medicine and Urology, Emeritus David Geffen School of Medicine at UCLA

Comments

CT Scans Can Reduce Lung Cancer Deaths, Study Finds

quotesThis long awaited trial performed by the National Cancer Institute demonstrates the benefits of low …quotes

member-photo

Dean Gesme, MD

FACP FACPE FASCO President, Minnesota Oncology

Comments

Amazon Is Hiring People to Break into the Multibillion-Dollar Pharmacy Market

quotesWatch closely as Amazon may seek to break traditional distribution models in the drug prescibing spa…quotes

member-photo

Jeff Patton, M.D.

CEO Tennessee Oncology

Comments

Genentech’s Shocking $2 Billion 340B Revelation

quotesGood for Genentech! The abuse of this program needs to end ASAP. I agree with the author and hope …quotes

member-photo

Thomas Marsland, MD

Vice President Integrated Community Oncology Network Former Community Representative ASCO Board of Directors

Comments

Cancer Drugs Are Getting Better and Dearer

quotesI have been and on again and off again reader of the Economist for a long time. This article rem…quotes

member-photo

William Harwin MD

Florida Cancer Specialists President and Managing Partner

Comments

Memorial Sloan Kettering to Offer DigniCap® Scalp Cooling Device in New York Metro Area Locations

quotesAt Florida Cancer Specialists we have been using DigniCap for several months at 3 of our site and it…quotes